These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9186757)

  • 1. Regulatory aspects of the introduction of new macronutrient substitutes.
    Rulis AM; Pellicore LS; Thorsheim HR
    Ann N Y Acad Sci; 1997 May; 819():22-8. PubMed ID: 9186757
    [No Abstract]   [Full Text] [Related]  

  • 2. Macronutrient substitutes: are regulatory options possible?
    Degnan FH
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S38-41. PubMed ID: 8801616
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction: safety and regulatory issues related to the use of macronutrient substitutes in the food supply.
    Masten LW
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S3-5. PubMed ID: 8801615
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of the workshop on safety and regulatory aspects of macronutrient substitutes. Washington, D.C., November 16, 1994.
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S1-62. PubMed ID: 8801609
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of macronutrient substitutes by the Food and Drug Administration.
    Rulis AM
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S47-50. PubMed ID: 8801618
    [No Abstract]   [Full Text] [Related]  

  • 6. The regulatory status of medical foods and dietary supplements in the United States.
    Mueller C
    Nutrition; 1999 Mar; 15(3):249-51. PubMed ID: 10198926
    [No Abstract]   [Full Text] [Related]  

  • 7. Concluding remarks on the proposed safety appraisal framework for evaluating macronutrient substitutes.
    Allgood G
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S60-1. PubMed ID: 8801621
    [No Abstract]   [Full Text] [Related]  

  • 8. Making room for differing dietary needs.
    Heckman JH
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S42-6. PubMed ID: 8801617
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA, medical foods, and patents.
    Czap A
    Altern Med Rev; 2002 Oct; 7(5):367-8. PubMed ID: 12410621
    [No Abstract]   [Full Text] [Related]  

  • 10. Fat substitutes: a regulatory perspective.
    Vanderveen JE; Glinsmann WH
    Annu Rev Nutr; 1992; 12():473-87. PubMed ID: 1503814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It's a food, it's a drug ... no, it's a medical food.
    King AB
    Nutrition; 1997 Mar; 13(3):247-8. PubMed ID: 9131695
    [No Abstract]   [Full Text] [Related]  

  • 12. Panel discussion: what is the future of macronutrient substitutes in North America?
    Borzelleca JF; Cheney M; Davidson MH; Degnan FH; Derfler PS; Forbes AL; Glinsmann W; Heckman JH; Miller SA; Rulis AM; Masten LW
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S51-9. PubMed ID: 8801619
    [No Abstract]   [Full Text] [Related]  

  • 13. Enteral solutions: is there a solution?
    Heymsfield SB
    Nutr Clin Pract; 1995 Feb; 10(1):4-7. PubMed ID: 7898417
    [No Abstract]   [Full Text] [Related]  

  • 14. The danger in food safety policies.
    Hall RH
    Can Med Assoc J; 1978 Jan; 118(1):83-7. PubMed ID: 620390
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on congressional hearings on the diet industry.
    Kicklighter JR
    Nutrition; 1991; 7(4):297-9. PubMed ID: 1802225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foods which simulate meat. The nutritional aspects of vegetable protein foods which are meat analogues. Report of the Panel on Novel Foods, Committee on Medical Aspects of Food Policy.
    Rep Health Soc Subj (Lond); 1980; 17():i-vii, 1-20. PubMed ID: 7367737
    [No Abstract]   [Full Text] [Related]  

  • 17. Postmarket surveillance to determine nutritional impact of macronutrient substitutes.
    Cheney M
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S22-4; discussion S31-7. PubMed ID: 8801612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposed model for safety assessment of macronutrient substitutes.
    Borzelleca JF
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S15-8. PubMed ID: 8801610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on substitutes that alter gastrointestinal physiology.
    Glinsmann W
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S27-30; discussion S31-7. PubMed ID: 8801614
    [No Abstract]   [Full Text] [Related]  

  • 20. Are fake fats and sugars for real?
    Yen P
    Geriatr Nurs; 1990; 11(4):204-5. PubMed ID: 2163961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.